Treatment of Pyridoxine (Vitamin B6) Deficiency
For pyridoxine deficiency, oral supplementation with 50-100 mg daily for one to two weeks is the recommended treatment for deficiency resulting from chronic poor dietary intake. 1
Diagnosis
Before initiating treatment, confirm the diagnosis by:
- Measuring plasma pyridoxal phosphate (PLP) levels, which is the standard method for determining vitamin B6 status
- In patients with inflammation or serious illness, red cell PLP should be measured instead 1
- Normal plasma PLP values range from 5-50 μg/L (20-200 nmol/L)
Treatment Protocol
Oral Supplementation
- For dietary deficiency: 50-100 mg daily for 1-2 weeks, followed by maintenance dose of 2-5 mg daily 1, 2
- For maintenance therapy: After initial treatment, continue with a daily multivitamin containing 2-5 mg pyridoxine 2
Parenteral Administration
- When oral administration is not feasible (anorexia, nausea, vomiting, impaired GI absorption, or perioperative conditions):
- 10-20 mg daily intramuscularly or intravenously for 3 weeks 2
- Follow with oral maintenance therapy
Special Clinical Scenarios
Isoniazid-induced deficiency:
Vitamin B6 dependency syndromes:
- May require up to 600 mg daily initially
- Followed by lifelong maintenance of 30 mg daily 2
Patients with chronic kidney disease:
Pyridoxine-dependent epilepsy:
- Initial dose: 100 mg IV (with respiratory support available)
- Long-term: 15-30 mg/kg/day in infants, up to 200 mg/day in neonates, and 500 mg/day in adults 4
Ethylene glycol poisoning:
- 50 mg IV every 6 hours 1
Nutritional Requirements in Specific Settings
- Enteral nutrition: Should deliver at least 1.5 mg pyridoxine per day in 1500 kcal 1
- Parenteral nutrition: Should deliver 4-6 mg pyridoxine per day 1
Monitoring and Follow-up
- PLP levels respond to intake within 6-10 days, reflecting liver stores 1
- Monitor for resolution of clinical symptoms:
- Seborrheic dermatitis
- Cheilosis and glossitis
- Microcytic anemia
- Neurological symptoms (convulsions, confusion, depression)
Caution: Toxicity Risk
- Long-term high-dose supplementation can cause sensory neuropathy
- Doses >500 mg/day have resulted in various side effects 1
- Negative effects reported with prolonged intake of 300 mg/day
- Long-term doses as low as 100 mg/day have been associated with Lhermitte signs (spinal cord effects) 1, 5
- Symptoms of toxicity include sensory neuropathy with ataxia, areflexia, impaired sensations, and dermatologic lesions 1
Prevention in High-Risk Groups
Prophylactic pyridoxine (25-50 mg/day) should be given to all persons at risk of neuropathy when receiving isoniazid therapy, including:
- Pregnant women
- Breastfeeding infants
- Persons with HIV
- Patients with diabetes, alcoholism, malnutrition, or chronic renal failure
- Elderly patients 1
For patients with peripheral neuropathy, increasing pyridoxine dose to 100 mg/day is recommended 1.
By following these guidelines, pyridoxine deficiency can be effectively treated while minimizing the risk of toxicity from excessive supplementation.